{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSomatostatin receptor‐2 (SSTR2) plays a pivotal role in mediating the inhibitory actions of somatostatin on endocrine as well as nonendocrine cells. In several studies of gastroenteropancreatic and pituitary tumors, SSTR2 activation has been shown to dampen hormone secretion by triggering membrane hyperpolarization and suppressing Ca²⁺‐dependent exocytosis. In pancreatic islets, for example, selective SSTR2 agonists mimic somatostatin’s effects on both α‐ and β‐cells, contributing to the inhibition of glucagon and insulin release. Moreover, experiments in tumor models have demonstrated that re‐expression of SSTR2 in otherwise receptor‐negative adenocarcinoma cells induces apoptosis and curbs proliferation via intracellular signaling pathways—including the inhibition of PI3K activity and activation of caspases—and even in fibroblasts SSTR2 engagement initiates a SHP‐1–dependent apoptotic program. Collectively, these findings indicate that SSTR2 functions as a key regulator of cell growth and secretory activity in endocrine tissues and beyond."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOwing to its almost ubiquitous overexpression in well‐differentiated neuroendocrine tumors and certain other neoplasms, SSTR2 has become a cornerstone for both diagnostic imaging and targeted therapy. High receptor levels facilitate the use of radiolabeled somatostatin analogs for scintigraphy and peptide receptor radionuclide therapy, as evidenced in thyroid tumors, pituitary adenomas, and even in pheochromocytomas or paragangliomas. In addition, refined immunohistochemical methods employing monoclonal antibodies against SSTR2 have not only allowed for more accurate tumor grading but have also aided in stratifying patients for therapeutic regimens with somatostatin analogs. Thus, SSTR2 serves a dual function as both a functional mediator of inhibitory signaling and as a robust biomarker for tumor detection and growth control."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in hormone suppression and tumor imaging, SSTR2 is intricately involved in receptor dynamics and molecular interactions that fine‐tune cell signaling. Agonist binding has been shown to modulate SSTR2 dimerization and internalization, thereby influencing downstream cascades such as the G protein–coupled activation of the IKK/NFκB pathway and the disruption of p85–PI3K complexes. SSTR2 is also subject to transcriptional and epigenetic regulation, which may affect its stability and function in diverse contexts including central nervous system regions implicated in neurodegenerative processes. In addition, heteromerization with receptors such as dopamine receptor‐2 further broadens the spectrum of its functional impact, with potential implications for both neuroendocrine and neurological disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "33", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "M Papotti, M Bongiovanni, M Volante, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-002-0609-x"}], "href": "https://doi.org/10.1007/s00428-002-0609-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12021920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12021920"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Julie Guillermet, Nathalie Saint-Laurent, Philippe Rochaix, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0136771100"}], "href": "https://doi.org/10.1073/pnas.0136771100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12490654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12490654"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Virgil A S H Dalm, P Martin van Hagen, Peter M van Koetsveld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00048.2003"}], "href": "https://doi.org/10.1152/ajpendo.00048.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12684217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12684217"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "J Bertherat, F Tenenbaum, K Perlemoine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2002-021895"}], "href": "https://doi.org/10.1210/jc.2002-021895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14602773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14602773"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Cheolyoung Park, Inmyung Yang, Jeongtaek Woo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: the relationship with endogenous srif activity and response to octreotide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.51.227"}], "href": "https://doi.org/10.1507/endocrj.51.227"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15118275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15118275"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Michael Grant, Brian Collier, Ujendra Kumar "}, {"type": "b", "children": [{"type": "t", "text": "Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M407310200"}], "href": "https://doi.org/10.1074/jbc.M407310200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15231824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15231824"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "M Filopanti, C Ronchi, E Ballarè, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-0132"}], "href": "https://doi.org/10.1210/jc.2005-0132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15914528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15914528"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Andrew M F Liu, Yung H Wong "}, {"type": "b", "children": [{"type": "t", "text": "Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M504264200"}], "href": "https://doi.org/10.1074/jbc.M504264200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16115892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16115892"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "J Guillermet-Guibert, N Saint-Laurent, L Davenne, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.cdd.4401939"}], "href": "https://doi.org/10.1038/sj.cdd.4401939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16645635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16645635"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Corinne Bousquet, Julie Guillermet-Guibert, Nathalie Saint-Laurent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7601279"}], "href": "https://doi.org/10.1038/sj.emboj.7601279"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16917505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16917505"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "E Ferrante, C Pellegrini, S Bondioni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Relat Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/erc.1.01191"}], "href": "https://doi.org/10.1677/erc.1.01191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16954443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16954443"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "M Druckenthaner, C Schwarzer, C Ensinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for Somatostatin receptor 2 in thyroid tissue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2006.08.005"}], "href": "https://doi.org/10.1016/j.regpep.2006.08.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16996150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16996150"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Edgar J Rolleman, Peter P M Kooij, Wouter W de Herder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Nucl Med Mol Imaging (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00259-007-0457-7"}], "href": "https://doi.org/10.1007/s00259-007-0457-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17546456"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17546456"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Alessandra Baragli, Haydar Alturaihi, Heather L Watt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2007.07.007"}], "href": "https://doi.org/10.1016/j.cellsig.2007.07.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17706924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17706924"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Tina Binderup, Ulrich Knigge, Anne Mellon Mogensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroendocrinology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000113128"}], "href": "https://doi.org/10.1159/000113128"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18196892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18196892"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jérôme Torrisani, Naïma Hanoun, Henrik Laurell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2007-1525"}], "href": "https://doi.org/10.1210/en.2007-1525"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18325993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18325993"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Michael Grant, Haydar Alturaihi, Philippe Jaquet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0334"}], "href": "https://doi.org/10.1210/me.2007-0334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18653781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18653781"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "V Barresi, C Alafaci, F Salpietro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18695896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18695896"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Thomas Fischer, Christian Doll, Stefan Jacobs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-1063"}], "href": "https://doi.org/10.1210/jc.2008-1063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18697876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18697876"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "A Durand, J Champier, A Jouvet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Neuropathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5414/npp27334"}], "href": "https://doi.org/10.5414/npp27334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18808065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18808065"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "C de Bruin, R A Feelders, A M Waaijers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/JME-08-0110"}], "href": "https://doi.org/10.1677/JME-08-0110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18852217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18852217"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Toru Tateno, Masako Kato, Yuji Tani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.k08e-186"}], "href": "https://doi.org/10.1507/endocrj.k08e-186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19318729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19318729"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ana Paula M Casarini, Raquel S Jallad, Emília M Pinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pituitary (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11102-009-0175-1"}], "href": "https://doi.org/10.1007/s11102-009-0175-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19330452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19330452"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "L Righi, M Volante, V Tavaglione, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdp334"}], "href": "https://doi.org/10.1093/annonc/mdp334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19759190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19759190"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jean Claude Reubi, Beatrice Waser, Renzo Cescato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2009-2487"}], "href": "https://doi.org/10.1210/jc.2009-2487"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20228164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20228164"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Fangyi Gu, Fredrick R Schumacher, Federico Canzian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-10-0507"}], "href": "https://doi.org/10.1158/1055-9965.EPI-10-0507"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20810604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20810604"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Claudia Ramírez, Sonia Cheng, Guadalupe Vargas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2011-3163"}], "href": "https://doi.org/10.1210/jc.2011-3163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22419713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22419713"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Balrik Kailey, Martijn van de Bunt, Stephen Cheley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00207.2012"}], "href": "https://doi.org/10.1152/ajpendo.00207.2012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22932785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22932785"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Laura Chinezu, Alexandre Vasiljevic, Emmanuel Jouanneau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2013.08.007"}], "href": "https://doi.org/10.1016/j.humpath.2013.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24182563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24182563"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "E Peverelli, E Giardino, D Treppiedi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2014-1063"}], "href": "https://doi.org/10.1210/en.2014-1063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24828612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24828612"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Marianne S Elston, Goswin Y Meyer-Rochow, Helen M Conaglen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2014.11.012"}], "href": "https://doi.org/10.1016/j.humpath.2014.11.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25554089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25554089"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Csaba Ádori, Laura Glück, Swapnali Barde, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00401-015-1394-3"}], "href": "https://doi.org/10.1007/s00401-015-1394-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25676386"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25676386"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Charlotte Gardair, Mahtab Samimi, Antoine Touzé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroendocrinology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000381062"}], "href": "https://doi.org/10.1159/000381062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25765179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25765179"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Evanthia Diakatou, Krystallenia I Alexandraki, Apostolos V Tsolakis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cen.12775"}], "href": "https://doi.org/10.1111/cen.12775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25808161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25808161"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Caiyun Xu, Hong Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor based imaging and radionuclide therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2015/917968"}], "href": "https://doi.org/10.1155/2015/917968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25879040"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25879040"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Lichun Sun, Qingqing Qian, Guangchun Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Drug Target (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/1061186X.2015.1066794"}], "href": "https://doi.org/10.3109/1061186X.2015.1066794"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26211366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26211366"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Cristiana Cruceanu, Powell Patrick Cheng Tan, Sanja Rogic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Psychiatry (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1176/appi.ajp.2015.14101279"}], "href": "https://doi.org/10.1176/appi.ajp.2015.14101279"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26238605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26238605"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Katja Kiseljak-Vassiliades, Mei Xu, Taylor S Mills, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2015.09.016"}], "href": "https://doi.org/10.1016/j.mce.2015.09.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26391562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26391562"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Abbas Agaimy, Michael Michal, Ladislav Hadravsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Diagn Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.anndiagpath.2016.05.003"}], "href": "https://doi.org/10.1016/j.anndiagpath.2016.05.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27402219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27402219"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "E Peverelli, E Giardino, D Treppiedi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.30613"}], "href": "https://doi.org/10.1002/ijc.30613"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28120505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28120505"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Jinyun Li, Cheng Chen, Xuer Bi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.07.082"}], "href": "https://doi.org/10.1016/j.gene.2017.07.082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28782576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28782576"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Matt Lechner, Volker H Schartinger, Christopher D Steele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-020-20308-8"}], "href": "https://doi.org/10.1038/s41467-020-20308-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33402692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33402692"}]}]}]}